checkAd
    Startseite > Aktien > Seres Therapeutics > Nachrichten
    Seres Therapeutics
    Aktie
    ISIN: US81750R1023 WKN: A14VXX SYM: 1S9 Land USA
    Zur Watchlist hinzufügen Zum Portfolio hinzufügen
    0,6584
     
    EUR
    -0,63 %
    -0,0042 EUR
    Letzter Kurs 14.06.24 Tradegate
    Geldkurs
    14.06.24
    0,6452
     
    EUR
    12.400 STK
    Briefkurs
    14.06.24
    0,6714
     
    EUR
    11.920 STK

    Seres Therapeutics Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    07.06.24 · globenewswire · Seres Therapeutics
    Seres Therapeutics Enters Into Memorandum of Understanding For Vowst Asset Sale to Nestlé Health Science
    06.06.24 · globenewswire · Seres Therapeutics
    Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
    08.05.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    06.05.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024
    06.05.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
    09.04.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    28.03.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    19.03.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024
    28.02.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference
    27.02.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz
    26.02.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    17.01.24 · Business Wire (engl.) · Seres Therapeutics